|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | C07D 471/20 |
| (11) | Patento numeris | 2825044 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 13760317.1 |
| Europos patento paraiškos padavimo data | 2013-03-13 | |
| (97) | Europos patento paraiškos paskelbimo data | 2015-01-21 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2018-08-15 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2013/030696 |
| Data | 2013-03-13 |
| (87) | Numeris | WO 2013/138418 |
| Data | 2013-09-19 |
| (30) | Numeris | Data | Šalis |
| 201261610746 P | 2012-03-14 | US | |
| 201261644648 P | 2012-05-09 | US |
| (72) |
BELYK, Kevin M., US
CLEATOR, Edward, GB
KUO, Shen-Chun, US
MALIGRES, Peter Emmanuel, US
XIANG, Bangping, US
YASUDA, Nobuyoshi, US
YIN, Jianguo, US
|
| (73) |
Merck Sharp & Dohme Corp.,
126 East Lincoln Avenue, Rahway, NJ 07065-0907,
US
|
| (54) | PROCESS FOR MAKING CGRP RECEPTOR ANTAGONISTS |
| PROCESS FOR MAKING CGRP RECEPTOR ANTAGONISTS |